SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pappy who wrote (391)1/29/1998 11:14:00 PM
From: Amy Feller  Read Replies (3) of 1754
 
>>Per inquiries from analysts in the conference call, Visx did not include revenues contested by the
illar Point suit. Including these recvenues would add greater than $5.0 MM to the bottom line,
or $.30 for a total of $.75 for the quarter.

There is no indication for this manouver in the press release.
Analysts did not sound very happy.
<<
Ok.. I'm admittedly very confused by the above statement and why
analysts would not be happy. My big question after seeing the
earnings was whether the PPP revenues were included or not. Now that
we know (per the above posting, I have not independently verified it)
they were NOT included.. isn't this more a sign of how good the
quarter was?

Someone please explain.

Amy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext